Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.

Preventive cardiology - 1 Jan 2010

Wilkins John T, Lloyd-Jones Donald M

Abstract excerpt

The following Point/Counterpoint articles were derived from a debate presentation sponsored by the American Society for Preventive Cardiology at the March 2010 meeting of the American Heart Association Council on Epidemiology and Prevention, titled "Should We Focus on Novel Risk Marker and Screening Tests to Better Predict and Prevent Cardiovascular Disease?" Dr. James de Lemos presented the pro side, titled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to C-Reactive Protein
Share to Coronary Artery Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Natriuretic Peptide, Brain

Share to Peptide Fragments

Share to Predictive Value of Tests

Share to Risk Assessment

Share to Troponin

Source

Identifiers

PMID: 20860638
DOI: 10.1111/j.1751-7141.2010.00081.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.PMID 20860638Read ↗

Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.Semantic proximity Read ↗

Redefining risk in acute coronary syndromes using molecular medicine.Semantic proximity Read ↗

Molecular signatures of cardiovascular disease risk: potential for test development and clinical application.Semantic proximity Read ↗

Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.Semantic proximity Read ↗

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Semantic proximity Read ↗

New biomarkers may predict CAD.Semantic proximity Read ↗

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Semantic proximity Read ↗

Cardiovascular Risk Assessment.Semantic proximity Read ↗

Cardiovascular risk prediction - a systems medicine approachSemantic proximity Read ↗

Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.Semantic proximity Read ↗

Update on risk factors for atherosclerosis: the role of inflammation and apolipoprotein E.Semantic proximity Read ↗

The American Heart Association's New Institute for Precision Cardiovascular Medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.